General Sessions:
- Best of Journals: Urothelial Carcinoma
- Optimizing Personalized Management of Nonmuscle-Invasive Bladder Cancer
- Meet the Regulators: History of FDA Perspective and Drug Development in Nonmuscle Invasive Bladder Cancer
- Navigating Uncertain Times in Muscle-Invasive and Advanced Bladder Cancer